Achieve Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-39.83	-29.82	-42.35	-33.15	-14.73	Upgrade
Depreciation & Amortization	0.23	0.23	0.24	0.25	0.26	Upgrade
Other Amortization	0.02	-	-	-	-	Upgrade
Stock-Based Compensation	5.33	3.44	3.27	2.19	1.29	Upgrade
Other Operating Activities	2.07	2.45	1.2	0.04	-	Upgrade
Change in Accounts Payable	1.33	-1.04	0.8	0.51	-0.53	Upgrade
Change in Other Net Operating Assets	1.08	0.26	-0.72	0.73	0.24	Upgrade
Operating Cash Flow	-29.77	-24.48	-37.57	-29.44	-13.47	Upgrade
Capital Expenditures	-	-0.02	-	-	-0.02	Upgrade
Investment in Securities	-21.58	-	-	-	-	Upgrade
Investing Cash Flow	-21.58	-0.02	-	-	-0.02	Upgrade
Long-Term Debt Issued	9.81	-	-	14.93	-	Upgrade
Total Debt Issued	9.81	-	-	14.93	-	Upgrade
Long-Term Debt Repaid	-18.11	-	-	-	-	Upgrade
Total Debt Repaid	-18.11	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	-8.3	-	-	14.93	-	Upgrade
Issuance of Common Stock	56.94	15.53	19.36	21.68	32.73	Upgrade
Repurchase of Common Stock	-0.11	-0.22	-0.05	-	-	Upgrade
Other Financing Activities	-	-0.03	-	-	-0.05	Upgrade
Financing Cash Flow	48.53	15.28	19.32	36.61	32.68	Upgrade
Foreign Exchange Rate Adjustments	-	-0	0	-0	-	Upgrade
Net Cash Flow	-2.82	-9.23	-18.25	7.17	19.19	Upgrade
Free Cash Flow	-29.77	-24.5	-37.57	-29.44	-13.49	Upgrade
Free Cash Flow Per Share	-0.93	-1.24	-3.55	-3.63	-4.96	Upgrade
Levered Free Cash Flow	-18.34	-15.43	-23.11	-17.06	-7.97	Upgrade
Unlevered Free Cash Flow	-17	-13.64	-21.99	-17.06	-7.97	Upgrade
Change in Net Working Capital	-1.87	0.26	-0	-1.19	0.28	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q